Financials
Income statement
Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
---|---|---|---|---|
Total reported revenue | 8.3B | 11.1B | 7.9B | 8.3B |
Cost of revenue | 4.2B | 6.0B | 4.3B | 4.4B |
Gross profit | 4.1B | 5.1B | 3.6B | 3.9B |
Operating expense | ||||
Research & development | 318M | 446M | 319M | 355M |
Selling general and admin | 2.8B | 3.0B | 2.5B | 2.7B |
Other operating expenses | 115M | -56M | 438M | -16M |
Operating income | 896M | 1.7B | 339M | 922M |
Non operating interest income | ||||
Income | — | — | — | — |
Expense | — | — | — | — |
Other income expense | — | — | — | — |
Pretax income | 428M | 911M | 32M | 700M |
Tax provision | 124M | 243M | 24M | 187M |
Net income | 304M | 668M | 8M | 513M |
Basic EPS | 1.1 | 2.4 | 0.0 | 1.9 |
Diluted EPS | 1.1 | 2.4 | 0.0 | 1.9 |
Basic average shares | 272.4M | 272.4M | 272.4M | 272.4M |
Diluted average shares | 272.4M | 272.4M | 272.4M | 272.4M |
EBITDA | 1.8B | 3.3B | 1.0B | 1.5B |
Net income from continuing op. | 598M | 1.1B | 184M | 830M |
Minority interests | -4M | -5M | -7M | 0 |
Preferred stock dividends | 0 | 0 | 0 | 0 |